The European Medicine Agency (EMA) human medicines committee (CHMP) just recommended granting an extension of indication for the COVID-19 vaccine Comirnaty, the mRNA-based vaccine, to include use in children aged 5 to 11. The vaccine, developed by BioNTech and Pfizer,...
Researchers from the North Bristol NHS Trust, Academic Respiratory Unit in Bristol, UK, recently uploaded study results to the medRxiv preprint server. The study team sought to identify if the corticosteroid dexamethasone, proven to reduce COVID-19 mortality in...
African timing plot twist The timing of announcements by the South African and Botswana governments, regarding a new ‘Omicron’ variant with 32 spike protein mutations, sent waves of fear but also disbelief around the world. Hong Kong announced two fully vaccinated...
The Omicron variant carries worrisome mutations that may let it evade antibodies, scientists said. But it will take more research to know how it fares against vaccinated people. By Carl Zimmer Scientific experts at the World Health Organization warned on Friday that a...
By Rebecca Robbins The pharmaceutical company Merck said on Friday that in a final analysis of a clinical trial, its antiviral pill reduced the risk of hospitalization and death among high-risk Covid patients by 30 percent, down from an earlier estimate of 50 percent....
by Nadine A Yehya, UC Davis With around 256 million cases and more than 5 million deaths worldwide, the COVID-19 pandemic has challenged scientists and those in the medical field. Researchers are working to find effective vaccines and therapies, as well as understand...
While a Phase 3 clinical trial investigating Merck’s molnupiravir in the Philippines seeks patients this isn’t a surprise given the imminent accessibility the drug now has to the local patient market. Currently allowed for compassionate use at several Philippines...
Standard Medicine principal investigators will receive nearly $15 million over a four-year term from the National Institutes of Health (NIH) to study long COVID. Stanford is but one of 30 research teams involved with the imminent, nationwide, NIH-sponsored RECOVER...
In what could be considered a striking discovery researchers form Harvard Medical School and Boston Children’s Hospital found that people taking the alcoholism drug disulfiram were 34% less likely to succumb to a SARS-CoV-2 infection, the virus behind COVID-19....
In a follow up to a story TrialSite first ran on November 15, a Chicago area judge “stood up” to Edward Hospital and ordered the medical institution to administer ivermectin to a “dying man.” “What’s the downside?’, asked Circuit Judge Paul Fullerton, according...
Another variant of coronavirus has been identified, this time the particle named B.1.1.529 seems to have a dangerous potential to generate a new wave of infections not only in its place of origin, South Africa but worldwide. According to the bioinformatics Túlio...
Britain, Israel and Singapore have restricted travel from the region. South African scientists will meet with W.H.O. experts on Friday. Scientists in South Africa on Thursday identified a concerning new coronavirus variant with mutations that one scientist said marked...
Results confirm that protection wanes with time and suggest a third (booster) dose might be warranted A study published by The BMJ today finds a gradual increase in the risk of covid-19 infection from 90 days after receiving a second dose of the...
Medical professionals are used to being believed, but as patients, they found that their expertise didn’t matter. By Ed Yong Before she caught COVID-19 at a wedding in March 2020, the physician associate spent her days diagnosing and treating people; after she was...
The B.1.1.529 variant was first spotted in Botswana and six cases have been found in South Africa By Ian Sample Scientists have said a new Covid variant that carries an “extremely high number” of mutations may drive further waves of disease by evading the body’s...